Trading glitch: NSE’s new offerings may run into SEBI hurdle

The regulator wants the exchange to expand its capacity to take orders as new services will put pressure on the market architecture and an interruption like the one on Wednesday could repeat.

Eveready Industries shares jump 20%, hit 52-week high

Owing to the default of payments, lenders of Eveready Industries have sold pledged shares in the last two years, dragging the shareholding of the Khaitan family to 4.5 percent from 44.1 percent.

NSE technical glitch | A look at some of the past instances of trading glitch globally

NSE has faced such technical glitches in the past as well. Such glitches are common globally as well. Most of the leading exchanges worldwide have encountered such glitches that have affected trading activities. Let’s take a look at some of the instances that have been reported from the around the world.

NSE Trading Halt: Outage calls for regulatory action to restore retail investor confidence

Retail equity participants are most vulnerable to the harmful effects of technical failures in the financial market

Indian stocks set for new record highs, but correction likely: Poll

A well-received union budget and a strong recovery in corporate earnings boosted the benchmark BSE Sensex Index to an all-time high of 52,516.76 on Feb. 16.

Technical glitch or blunder, it’s high time to make NSE answerable

While the market was shut on account of the technical glitch, the finance minister made market-sensitive announcements, as a result of which no sooner did the market open did we see panic short covering, especially on the Bank Nifty

NSE trading interruption: What exactly is a technical glitch, how does it impact investors, and other questions answered

Technical glitches as the ones that halted trading on the National Stock Exchange on February 24 have become recurring in recent years. Here is what you need to know about such hiccups on the stock exchanges.

Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules

The approved product is a generic version of Lundbeck NA Ltd's Northera capsules.

BSE market-cap nears $2.7 trillion, how many months could it take to hit $3 trillion?

The future earnings trajectory is very strong and a higher upside in the overall market could be a function of how much more earnings upgrades we see going forward.

Stock Exchanges | The more the merrier?

It is hard to argue against SEBI’s intent to foster competition for stock exchanges and depositories. However, it is unclear if adding more stock exchanges will accomplish the desired outcome

Investors registered with BSE hits record high

Glenmark Pharma gets USFDA nod for nervous system stimulant drug

The approved product is a generic version of Evekeo tablets of Arbor Pharmaceuticals LLC.

Investors' wealth plunge over Rs 8 lakh crore in four days

Recordings its fourth straight session of loss on Wednesday, the Sensex tumbled 937.66 points or 1.94 percent to close at 47,409.93. In the four straight sessions, the benchmark has fallen by 2,382.19 points or 4.78 percent.

Alembic Pharma gets USFDA nod for low blood pressure treatment drug

The approved product is therapeutically equivalent to the reference listed drug product ProAmatine tablets of Takeda Pharmaceuticals USA, Inc.

Mindtree shares close over 1% higher as net profit jumps

The Bengaluru-based company had posted a net profit of Rs 197 crore in the year-ago period. Its revenue grew 3 per cent to Rs 2,023.7 crore in the quarter under review, from Rs 1,965.3 crore in the year-ago period.

Market cap of BSE-listed companies crosses GDP, first time since 2007

BSE market capitalisation is up by nearly 75 percent since March 2020.

M-cap of BSE-listed companies at all-time high of Rs 197.46 lakh crore

At close of trade, the market capitalisation of BSE-listed companies stood at Rs 1,97,46,939.57 crore ($2.6 trillion).

SEBI’s plan for new bourses overlooks ground realities

The advantage of bringing in a foreign player in the exchange business is more than allowing a domestic player to start an exchange

M-cap of BSE-listed companies zoom to fresh record high of over Rs 195.21 lakh crore

The BSE Sensex surged 471.31 points to a high of 48,564.63 on Friday.

BSE-listed companies' market-cap zooms to record Rs 193.18 lakh crore

The BSE benchmark Sensex slipped nearly 81 points to close at 48,093.32 on Thursday despite opening with gains.

CN Infrabuild sells shares worth over Rs 276 crore in PNC Infratech

On the BSE, the entity sold 1.57 crore shares of PNC Infratech at an average price of Rs 175 apiece.

M-cap of BSE-listed companies zoom to record high of over Rs 191 lakh crore

Till Monday’s trade, markets recorded their ninth straight session of gain. During this time, the BSE Sensex jumped 2,622.84 points or 5.75 percent and closed above the 48,000-mark for the first time on Monday.

BSE deepens network in bullion trade; signs pact with Bihar's Patliputra Sarafa Sangh

The association would enable growth and development of value chain participants and enable them to face competition and manage price risks better.

Market holidays in 2021: Check days when BSE will be shut for trading

The Exchange may alter/change any of the above holidays, for which a separate circular shall be issued in advance.

3 Point Analysis | IT, Pharma were best performing sectors of 2020; will they continue to rally in 2021?

The IT and healthcare sectors are the biggest gainers of 2020. While the BSE information technology index surged 47% and healthcare index climbed 57 percent in 2020. They have gained 103% and 92% from March lows. In this edition of three point analysis we find out if the rally will continue in 2021 and what should investors do.